Patents by Inventor Christophe Boutillon

Christophe Boutillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
    Patent number: 6015564
    Abstract: Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide part having between 10 and 40 amino acids approximately and comprising at least one tigenic determinant. The lipopeptides also comprise one or more chains derived from fatty acids and one or more modified steroid groups. Said lipopeptides may be used for immunizing the human or animal body against pathogenic agents such as viruses or parasites. The peptide part may, in particular, be a fragment of the protein encoded by the ENV gene, by the NEF gene or by the GAG gene of HIV viruses.
    Type: Grant
    Filed: February 10, 1999
    Date of Patent: January 18, 2000
    Assignees: Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Christophe Boutillon, Frederic Martinon, Christian Sergheraert, Remy Magne, Helene Gras-Masse, Elisabeth Gomard, Andre Tartar, Jean-Paul Levy
  • Cytotoxic T lymphocyte-inducing lipopeptides and methods of use
    Patent number: 5993823
    Abstract: Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide fragment having approximately between 10 and 40 amino acids and comprising at least one antigenic determinant and also comprising one or more chains derived from fatty acids and one or more modified steroid groups useful for immunizing a human or animal body against pathogenic agents such as viruses or parasites which fragment is preferably a fragment of the protein encoded by the ENV gene, by the NEF gene or by the GAG gene of HIV viruses.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 30, 1999
    Assignee: Institut Pasteur de Lille
    Inventors: Christophe Boutillon, Frederic Martinon, Christian Sergheraert, Remy Magne, Helene Gras-Masse, Elisabeth Gomard, Andre Tartar, Jean-Paul Levy
  • Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
    Patent number: 5871746
    Abstract: Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide part having between 10 and 40 amino acids approximately and comprising at least one antigenic determinant. The lipopeptides also comprise one or more chains derived from fatty acids and one or more modified steroid groups.Said lipopeptides may be used for immunizing the human or animal body against pathogenic agents such as viruses or parasites. The peptide part may, in particular, be a fragment of the protein encoded by the ENV gene, by the NEF gene or by the GAG gene of HIV viruses. DA.
    Type: Grant
    Filed: May 31, 1994
    Date of Patent: February 16, 1999
    Assignees: Institut National de la Sainte et de la Recherche Medicale (INSERM), Institut Pasteur, Institut Pasteur De Lille
    Inventors: Christophe Boutillon, Frederic Martinon, Christian Sergheraert, Remy Magne, Helene Gras-Masse, Elisabeth Gomard, Andre Tartar, Jean-Paul Levy